Donor-Derived Anti-CD19 Chimeric-Antigen-Receptor-Expressing T Cells Cause Regression Of Malignancy Persisting After Allogeneic Hematopoietic Stem Cell Transplantation
Year: 2013
Type: article
Source: Blood
Authors: James N Kochenderfer, Mark E. Dudley, Robert O. Carpenter, Sadik H Kassim, Jeremy J. Rose, William Telford, Frances T Hakim, David Halverson, Daniel H. Fowler, Nancy M. Hardy, Anthony Mato, Dennis D. Hickstein, Juan Gea-Banacloche, Steven Z. Pavletic, Claude Sportes, Irina Maric, Steven Feldman, Brenna G Hansen, Jennifer Wilder, Bazetta Blacklock-Schuver, Bipulendu Jena, Michael Bishop, Steven A. Rosenberg, Ronald E. Gress
Institutions: National Cancer Institute, National Institutes of Health, Center for Cancer Research, Hackensack University Medical Center, National Institutes of Health Clinical Center, Science Applications International Corporation (United States), The University of Texas MD Anderson Cancer Center, University of Chicago Medical Center
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W74443612